These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 26816833)

  • 21. What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel.
    Moldovan PC; Van den Broeck T; Sylvester R; Marconi L; Bellmunt J; van den Bergh RCN; Bolla M; Briers E; Cumberbatch MG; Fossati N; Gross T; Henry AM; Joniau S; van der Kwast TH; Matveev VB; van der Poel HG; De Santis M; Schoots IG; Wiegel T; Yuan CY; Cornford P; Mottet N; Lam TB; Rouvière O
    Eur Urol; 2017 Aug; 72(2):250-266. PubMed ID: 28336078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histology core-specific evaluation of the European Society of Urogenital Radiology (ESUR) standardised scoring system of multiparametric magnetic resonance imaging (mpMRI) of the prostate.
    Kuru TH; Roethke MC; Rieker P; Roth W; Fenchel M; Hohenfellner M; Schlemmer HP; Hadaschik BA
    BJU Int; 2013 Dec; 112(8):1080-7. PubMed ID: 23937255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Confirmatory biopsy of men under active surveillance: extended versus saturation versus multiparametric magnetic resonance imaging/transrectal ultrasound fusion prostate biopsy.
    Pepe P; Cimino S; Garufi A; Priolo G; Russo GI; Giardina R; Reale G; Pennisi M; Morgia G
    Scand J Urol; 2017 Aug; 51(4):260-263. PubMed ID: 28513296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
    Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA
    J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined T2 and diffusion-weighted MR imaging with template prostate biopsies in men suspected with prostate cancer but negative transrectal ultrasound-guided biopsies.
    Sheikh N; Wei C; Szewczyk-Bieda M; Campbell A; Memon S; Lang S; Nabi G
    World J Urol; 2017 Feb; 35(2):213-220. PubMed ID: 27236302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of multiparametric prostate MRI in the management of prostate cancer.
    O'Connor LP; Lebastchi AH; Horuz R; Rastinehad AR; Siddiqui MM; Grummet J; Kastner C; Ahmed HU; Pinto PA; Turkbey B
    World J Urol; 2021 Mar; 39(3):651-659. PubMed ID: 32583039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective study investigating the impact of multiparametric MRI in biopsy-naïve patients with clinically suspected prostate cancer: The PROKOMB study.
    Baur ADJ; Henkel T; Johannsen M; Speck T; Weißbach L; Hamm B; König F
    Contemp Clin Trials; 2017 May; 56():46-51. PubMed ID: 28279782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiparametric MRI and targeted prostate biopsy: Improvements in cancer detection, localization, and risk assessment.
    Bjurlin MA; Mendhiratta N; Wysock JS; Taneja SS
    Cent European J Urol; 2016; 69(1):9-18. PubMed ID: 27123316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive zonal fusion biopsy of the prostate: Original technique between target and saturation.
    Galosi AB; Maselli G; Sbrollini G; Donatelli G; Montesi L; Tallè M; Montironi R
    Arch Ital Urol Androl; 2016 Dec; 88(4):292-295. PubMed ID: 28073195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer: A Systematic Review.
    Haider MA; Yao X; Loblaw A; Finelli A
    Clin Oncol (R Coll Radiol); 2016 Sep; 28(9):550-67. PubMed ID: 27256655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance of multiparametric prostate magnetic resonance imaging validated by targeted and systematic transperineal biopsies.
    Hsi RA; Dinh TK; Greer M; Bensen C; Mitchell MA; Li AY; Stamm A; Henne M
    BJUI Compass; 2023 Jan; 4(1):96-103. PubMed ID: 36569501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct comparison of multiparametric magnetic resonance imaging (MRI) results with final histopathology in patients with proven prostate cancer in MRI/ultrasonography-fusion biopsy.
    Borkowetz A; Platzek I; Toma M; Renner T; Herout R; Baunacke M; Laniado M; Baretton G; Froehner M; Zastrow S; Wirth M
    BJU Int; 2016 Aug; 118(2):213-20. PubMed ID: 26935133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of free-hand transperineal targeted prostate biopsy using multiparametric magnetic resonance imaging-transrectal ultrasound fusion in Chinese men with prior negative biopsy and elevated prostate-specific antigen.
    Lian H; Zhuang J; Wang W; Zhang B; Shi J; Li D; Fu Y; Jiang X; Zhou W; Guo H
    BMC Urol; 2017 Jul; 17(1):52. PubMed ID: 28679370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiparametric MRI and MRI/TRUS Fusion Guided Biopsy for the Diagnosis of Prostate Cancer.
    Schütz V; Kesch C; Dieffenbacher S; Bonekamp D; Hadaschik BA; Hohenfellner M; Radtke JP
    Adv Exp Med Biol; 2018; 1096():87-98. PubMed ID: 30324349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Utility of Multiparametric Magnetic Resonance Imaging as the First-line Tool for Men with High Clinical Suspicion of Prostate Cancer.
    Panebianco V; Valerio MC; Giuliani A; Pecoraro M; Ceravolo I; Barchetti G; Catalano C; Padhani AR
    Eur Urol Oncol; 2018 Aug; 1(3):208-214. PubMed ID: 31102623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endorectal power Doppler/grayscale ultrasound-guided biopsies vs. multiparametric MRI/ultrasound fusion-guided biopsies in males with high risk of prostate cancer: A prospective cohort study.
    He Z; Yuan Z; Liang L; Xie XI; Yuan J; He W; Chen J; Kuang Y
    Exp Ther Med; 2019 Dec; 18(6):4765-4773. PubMed ID: 31807154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First report of robot-assisted transperineal fusion versus off-target biopsy in patients undergoing repeat prostate biopsy.
    Kaufmann S; Mischinger J; Amend B; Rausch S; Adam M; Scharpf M; Fend F; Kramer U; Notohamiprodjo M; Nikolaou K; Stenzl A; Bedke J; Kruck S
    World J Urol; 2017 Jul; 35(7):1023-1029. PubMed ID: 27847972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of multiparametric MRI and MRI-targeted biopsy on pre-therapeutic risk assessment in prostate cancer patients candidate for radical prostatectomy.
    Dell'Oglio P; Stabile A; Dias BH; Gandaglia G; Mazzone E; Fossati N; Cucchiara V; Zaffuto E; Mirone V; Suardi N; Mottrie A; Montorsi F; Briganti A
    World J Urol; 2019 Feb; 37(2):221-234. PubMed ID: 29948044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 18F-Choline PET/MRI: The Additional Value of PET for MRI-Guided Transrectal Prostate Biopsies.
    Piert M; Montgomery J; Kunju LP; Siddiqui J; Rogers V; Rajendiran T; Johnson TD; Shao X; Davenport MS
    J Nucl Med; 2016 Jul; 57(7):1065-70. PubMed ID: 26985061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does 1.5 T mpMRI play a definite role in detection of clinically significant prostate cancer? Findings from a prospective study comparing blind 24-core saturation and targeted biopsies with a novel data remodeling model.
    Dal Moro F; Zecchini G; Morlacco A; Gardiman MP; Lacognata CS; Lauro A; Rugge M; Prayer Galetti T; Zattoni F
    Aging Clin Exp Res; 2019 Jan; 31(1):115-123. PubMed ID: 29616473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.